Impact of FDA endorsement and modified risk versus exposure messaging in IQOS ads: a randomised factorial experiment among US and Israeli adults
Sign Up to like & getrecommendations! Published in 2022 at "Tobacco Control"
DOI: 10.1136/tc-2022-057639
Abstract: Background IQOS was the first heated tobacco product to receive Food and Drug Administration (FDA) authorisation for ‘reduced exposure’ marketing claims, which has been exploited globally. Methods In November–December 2021, we conducted a survey-based 3×3… read more here.
Keywords: control; exposure messaging; risk; factorial experiment ... See more keywords